思維列控(603508.SH):遠望谷解除質押310萬股
格隆匯4月14日丨思維列控(603508.SH)公佈,公司於2020年4月14日收到持股5%以上非第一大股東深圳市遠望谷信息技術股份有限公司(以下簡稱“遠望谷”)通知,遠望谷已於2020年4月10日辦理了解除股份質押的手續,將其質押給中國光大銀行股份有限公司深圳分行的思維列控無限售流通股310萬股解除質押。
遠望谷持有公司股份1598.798萬股,佔公司總股本的8.21%。遠望谷本次解除質押無限售流通股310萬股後,遠望谷累計質押股份數量為310萬股,佔其持有公司股份數量的19.39%,佔公司總股本的1.59%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.